- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Piramal Pharma Ltd (PIRM)
Track today's live Piramal Pharma (PIRM) share price, performance and key data on this page with our current NSE:PIRM stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Piramal Pharma share price on the NSE exchange. Use the dropdown to switch exchange for the PIRM share price, head to our technical summary section, which provides analysis on Piramal Pharma share price buy/sell indicators using real-time data (or discuss the Piramal Pharma (PIRM) stock price today with other investors in the Piramal Pharma NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:PIRM share price (ISIN: INE0DK501011) to enhance your trading decisions with our free investment tools and resources.
What Is the Piramal Pharma Ltd Share Price Today?
The Piramal Pharma share price today is 246.37.
What Is the Stock Symbol for Piramal Pharma Ltd
The stock symbol (or 'ticker') for Piramal Pharma Ltd is "PIRM."
What Stock Exchange Does Piramal Pharma Ltd Trade On?
Piramal Pharma Ltd is listed and trades on the NSE stock exchange.
Is Piramal Pharma Ltd a Good Stock to Buy?
Determining whether Piramal Pharma (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:PIRM share price (ISIN: INE0DK501011) to enhance your trading decisions with our free investment tools and resources.
What Is the Piramal Pharma Ltd Share Price Today?
The Piramal Pharma share price today is 246.37.
What Is the Stock Symbol for Piramal Pharma Ltd
The stock symbol (or 'ticker') for Piramal Pharma Ltd is "PIRM."
What Stock Exchange Does Piramal Pharma Ltd Trade On?
Piramal Pharma Ltd is listed and trades on the NSE stock exchange.
Is Piramal Pharma Ltd a Good Stock to Buy?
Determining whether Piramal Pharma (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
246.37
+0.17(+0.07%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
242.50
250.40
52 wk Range
132.30
250.40
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
242.50250.40
52 wk Range
132.30250.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PPLPHARMA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
262.91
Upside
+6.71%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Piramal Pharma receives Investment Bank Analyst Rating Update- Investing.com
Pro
Piramal Pharma receives Investment Bank Analyst Rating Update- Investing.com
Pro
Piramal Pharma acquires majority stake in Yapan Bio for $7.95M- Investing.com
Pro
- Piramal Pharma acquires majority stake in Yapan Bio for $7.95M
- Investing.com
Pro 
Piramal Pharma receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
11 Buy
0 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 262.91
(+6.71% Upside)
Piramal Pharma Ltd Earnings Call Summary for Q2/2027
- Q2 revenue rose 28% YoY to INR 2,617 crores; EBITDA surged 72% to INR 385 crores with 350+ bps margin expansion, driving shares up 14%.
- Management raised FY2027 revenue growth guidance to 19-20% from mid-teens, citing strong CDMO order momentum and seasonally stronger H2.
- CDMO business led growth at 36% YoY, driven by ADC work, on-patent manufacturing, and multi-geography strategy validation in North America.
- Net debt-to-EBITDA improved to 3.4x from 3.7x; consumer healthcare targets double-digit OTC margins by FY2030 through premiumization.
- Regulatory observations at Morpeth facility and Kenalog supply transition remain key risks; Bayer distribution agreement expires December 2026.
Last Updated: 28/10/2026, 06:02
Read Full TranscriptEarnings
Latest Release
27/10/2026
EPS / Forecast
-- / -0.38
Revenue / Forecast
26.17B / 23.46B
Compare PPLPHARMA to Peers and Sector
Metrics to compare | PPLPHARMA | Peers Peers - average of corresponding metrics from companies closely matching PPLPHARMA: ONESOURCE, LAURUSLABS, DCAL, SAILIFE, MANKIND | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPPLPHARMAPeersSector |
|---|---|---|---|---|
P/E Ratio | −156.8x | 41.2x | −0.2x | |
PEG Ratio | 0.21 | 1.04 | 0.00 | |
Price/Book | 4.0x | 4.1x | 2.6x | |
Price / LTM Sales | 3.3x | 4.8x | 2.8x | |
Upside (Analyst Target) | 6.7% | 3.7% | 60.9% | |
Fair Value Upside | Unlock | 2.3% | 9.5% | Unlock |
Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing; offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain management drugs, and other generic and speciality products; and analgesics, skin care, vitamin and mineral supplement, kids’ wellness, digestives, and women’s health, as well as geriatric care. In addition, the company operates as a contract development and manufacturing organization, providing process development, scale-up, and GMP manufacturing services for vaccines and biologics. The company was incorporated in 2020 and is based in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Piramal Pharma (NSE: PPLPHARMA) Share Price Today?
The Piramal Pharma stock price today is 246.37 INR.
What Stock Exchange Does Piramal Pharma (PPLPHARMA) Trade On?
Piramal Pharma is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Piramal Pharma?
The stock symbol (also called a 'ticker') for Piramal Pharma is "PPLPHARMA."
What Is the Current Piramal Pharma Market Capitalisation?
As of today, Piramal Pharma (NSE: PPLPHARMA) market cap is 327.49B INR.
What Is Piramal Pharma's (PPLPHARMA) Earnings Per Share (TTM)?
The Piramal Pharma EPS is currently -1.57 (Trailing Twelve Months).
When Is the Next Piramal Pharma Earnings Date?
Piramal Pharma's next earnings report will be released on 02/02/2027.
Is PPLPHARMA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Piramal Pharma moving averages and other technical indicators, the daily buy/sell signal for PPLPHARMA stock is Strong Buy.
How Many Times Has Piramal Pharma Stock Split?
Piramal Pharma has split 0 times. (See the PPLPHARMA stock split history page for full effective split date and price information.)
How Many Employees Does Piramal Pharma Have?
Piramal Pharma has 7120 employees, based on their latest Companies House report.
What is the current trading status of Piramal Pharma (NSE: PPLPHARMA)?
As of 11/11/2026, Piramal Pharma (PPLPHARMA) is trading at a share price of 246.37 INR, with a previous close of 246.37 INR. The stock has fluctuated within a day range of 242.50 INR to 250.40 INR, while its 52-week range spans from 132.30 INR to 250.40 INR.
What Is Piramal Pharma (PPLPHARMA) Price Target According to Analysts?
The average 12-month price target for Piramal Pharma is 262.91 INR, with a high estimate of 300 INR and a low estimate of 220 INR. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +6.71% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.